C2Care
Designs therapeutic solutions based on virtual reality in order to immerse patient in an environment that creates a certain stress.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
$1.1m | Early VC | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 369 % | 45 % | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (52 %) | - | (43 %) | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (43 %) | (14 %) | (48 %) | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
C2Care, established in 2015 by the collaborative friendship of Romain Streichemberger and Pierre Gadea, develops virtual reality (VR) based therapeutic tools for healthcare professionals. The founders' journey began after an encounter with a doctor specializing in VR-based phobia treatment, which inspired them to apply their expertise to advance mental health solutions. Streichemberger, a computer engineer with a background in the video game industry, serves as the company's President, while Gadea functions as CEO.
The company's core business revolves around providing a software platform that utilizes Virtual Reality Exposure Therapy (VRET), a method grounded in Cognitive Behavioral Therapy (CBT) principles. This technology is designed to treat a wide array of psychological conditions, including phobias, anxiety, addictions, eating disorders, and post-traumatic stress disorder. C2Care's platform features over a hundred immersive and reproducible virtual environments, allowing therapists to expose patients to anxiety-inducing situations in a controlled, safe, and gradual manner. The environments are enhanced with artificial intelligence, featuring a virtual coach and characters that replicate realistic social interactions to improve the therapeutic experience.
C2Care operates on a B2B model, serving healthcare professionals in private practice, hospitals, and clinics, as well as those conducting teleconsultations. The business generates revenue through the sale of its VR software solutions, which are recognized as Class 1 Medical Devices. To date, the Toulon-based company has secured approximately $1.8M in funding through several rounds, including a significant seed round in January 2020, with investors like Turenne Groupe, Olbia Invest, and Creazur France. This financial backing supports the company's mission to make mental healthcare more accessible and to continuously advance its technology.
Keywords: virtual reality therapy, mental health technology, cognitive behavioral therapy, VRET, exposure therapy, digital therapeutics, phobia treatment, anxiety treatment, addiction treatment, PTSD treatment, healthcare software, medical device, neuropsychology, psychotherapy tools, immersive therapy, behavioral health, teleconsultation, health tech, Romain Streichemberger, Pierre Gadea